•Lunai Bioworks signed a definitive collaboration agreement with BrainStorm Therapeutics to develop an integrated roadmap for Parkinson's disease treatment.
•Initial Parkinson's disease data readout is targeted for the first half of 2027.
•Newbridge Acquisition Limited announced the execution of a business combination agreement with Startech Group Inc., a life sciences technology company.
•Startech focuses on developing functional water and AI-powered healthcare technologies to enhance human longevity.